Joel Greenblatt

Joel Greenblatt

Last Update: 11-15-2016

Number of Stocks: 913
Number of New Stocks: 219

Total Value: $7,679 Mil
Q/Q Turnover: 29%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Joel Greenblatt' s Profile & Performance

Profile

Known for the invention of Magic Formula Investing, and founder of the New York Securities Auction Corporation (NYSAC). Greenblatt is founder and managing partner of Gotham Asset Management, LLC. He is the author of two investment books, including Joel Greenblatt: The little Book that Beats the Market. He is also an Adjunct Professor with Columbia Business School.

Investing Philosophy

Greenblatt tries to find cheap and good companies. He looks for value with a catalyst, so nice things happen sooner. Greenblatt likes special situations, and thinks that they are simply different places to find cheap stocks. In his own hedge fund, Greenblatt uses the basic principals in the Magic Formula: Look for high ROC and high earnings yield. He tries to figure out what "normalized earnings" will be 3-4 years into the future. Greenblatt makes sure the stock is very cheap based on normalized earnings. He is very concentrated in investing, 5 to 8 securities can make up 80% of his portfolio. One position could be as high as 30%.

Total Holding History

Performance of Gotham Absolute Return Fund

YearReturn (%)S&P500 (%)Excess Gain (%)
2015-10.241.19-11.4
20149.3113.69-4.4
201329.8132.39-2.6
3-Year Cumulative27.4 (8.4%/year)52.3 (15.1%/year)-24.9 (-6.7%/year)

Top Ranked Articles

On Diversification Diversification is not an easy subject, but by analyzing data and applying some logic you can narrow down an optimal strategy
​The age-old question of exactly how many stocks to hold is likely never going to be definitively answered. There are entire books, even courses, on the subject after all. Since portfolio construction is more of an art than a science, in this post I want to break down relevant studies, examine historical data and analyze some of the best investors in an attempt to come up with the optimal strategy. As always, please share your comments and thoughts below! Read more...
Calculating the Return on Incremental Capital Investments As a business owner, you want to know where you can reinvest your company’s excess cash flow and what rate of return you can get from those investments.
“Leaving the question of price aside, the best business to own is one that over an extended period can employ large amounts of incremental capital at very high rates of return.” –Warren Buffett (Trades, Portfolio), 1992 Shareholder Letter Read more...
Does Joel Greenblatt’s Magic Formula Have a Solution for Value Investors? Exploring the Magic Formula and assessing its potential
When investment guru Joel Greenblatt (Trades, Portfolio) taught at an Ivy League college, he would welcome each new class with a request: Shout out the names of big, well-known public companies. After getting the names, Greenblatt would pull out a newspaper (yes, we depended on newspapers for that sort of thing in the not so distant past), then announce the current price, the 52-week low and the 52-week high for each of them. Read more...
18 Questions With John Huber of Saber Capital Management Goal: 'Make meaningful investments in high-quality businesses at attractive prices'
1. How and why did you get started investing? What is your background? Read more...
25 Questions With Chris DeMuth Jr. of Rangeley Capital 'If it is legal and there is limited liability, I would be delighted to invest in anything at the right price'
Chris DeMuth Jr. is the founder of Rangeley Capital LLC. Rangeley is an investment firm that focuses on event-driven, value-oriented investment opportunities. Rangeley Capital and DeMuth's value investing forum, Sifting the World (StW), search the world for misplaced bets. Rangeley exploits them for its investors and DeMuth writes about them on StW Read more...
» More Joel Greenblatt Articles

Commentaries and Stories

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Altria Buys Sherman Group Holdings Acquisition adds premium products to company's smokable segment Joel Greenblatt,Barrow Hanley Mewhinney & Strauss, - Altria Buys Sherman Group Holdings
Altria Group Inc. (NYSE:MO) announced through the Business Wire the acquisition of the privately held Sherman Group Holdings and its subsidiary companies. The conditions of the deal are undisclosed. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Undervalued Stocks Trading Below Peter Lynch Value Gurus are buying these companies First Eagle Investment,Joel Greenblatt,Mario Gabel - Undervalued Stocks Trading Below Peter Lynch Value
According to GuruFocus' All-in-One Screener, several gurus are focusing on stocks whose Peter Lynch fair values are far above the current prices. The following stocks are trading with wide margins of safety and at least five gurus are shareholders. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Eldorado Gold Reports Preliminary Operating Results for 2016 Gold production for the year slightly lower than expected Charles Brandes,Joel Greenblatt - Eldorado Gold Reports Preliminary Operating Results For 2016
Eldorado Gold Corp. (NYSE:EGO) announced its preliminary operational results for 2016 and its guidance for 2017 last Friday. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Harmony Merger Inks Deal Greenblatt Favors Company and special adviser make their move by merging with MUNDOmedia Joel Greenblatt,Seth Klarman - Harmony Merger Inks Deal Greenblatt Favors
Harmony Merger (NASDAQ:HRMN) came public as a blank check company – a company with nothing but cash and the intentions of making an acquisition. More...

JOEL GREENBLATT


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Valero Energy Upgraded by Bank of America Merrill Lynch Deutsche Bank downgraded the energy stock from Buy to Hold the same day Joel Greenblatt,Ron Baron,David Dreman,Ken Fisher - Valero Energy Upgraded By Bank Of America Merrill Lynch
Valero Energy Corp. (NYSE:VLO) got two opposite ratings Jan. 5. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

British American Tobacco Deal With Reynolds American Hits Road Bump British American hopes to buy American tobacco producer for $56.50 per share Joel Greenblatt,Ken Fisher - British American Tobacco Deal With Reynolds American Hits Road Bump
A deal for British American Tobacco (BTI) to buy the rest of Reynolds American (NYSE:RAI) for $47 billion in cash and stock, has run into an unexpected problem, as reported by the website StreetInsider.com More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Lannet's Lopinavir, Ritonavir Approved to Treat HIV in US Company’s protease inhibitors are equivalent to AbbVie’s Kaletra oral solution Joel Greenblatt,Ken Fisher,Ronald Muhlenkamp - Lannet's Lopinavir, Ritonavir Approved To Treat HIV In US
Lannet Co. Inc. (NYSE:LCI) announced through the PRNewswire Tuesday that its “Lopinavir and Ritonavir Oral Solution USP, 80 mg/20 mg per mL” has been approved by the U.S. Food and Drug Administration (FDA) to be produced and sold in the U.S. as a generic drug. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

20 Questions With Value Investor Victor Huynh 'Depending on the nature of the business, I would value it based on its asset valuations, then earnings power, then growth potential' Joel Greenblatt,Warren Buffett - 20 Questions With Value Investor Victor Huynh
1. How and why did you get started in investing? What is your background? More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

How to Invest in Gold in 2017 Part 5 Eldorado Gold will benefit from mine development and strengthening its balance sheet Charles Brandes,Joel Greenblatt - How To Invest In Gold In 2017 Part 5
Gold for immdediate delivery witnessed a significant jump today. The precious metal increased by 1.08% on the London Bullion Market, up $12.2 per troy ounce to $1,146.80 per troy ounce from yesterday's closing price of $1,134.60. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

25 Questions With Tom Vilord of Vilord Wealth Advisors '99% of the people wouldn’t follow' a checklist from Warren Buffett for analyzing a company Warren Buffett,Joel Greenblatt,Seth Klarman,Mohnis - 25 Questions With Tom Vilord Of Vilord Wealth Advisors
1. How and why did you get started investing? What is your background? More...

  • Currently 5.00/5

Rating: 5.0/5 (3 votes)

25 Questions With Chris DeMuth Jr. of Rangeley Capital 'If it is legal and there is limited liability, I would be delighted to invest in anything at the right price' Joel Greenblatt - 25 Questions With Chris DeMuth Jr. Of Rangeley Capital
Chris DeMuth Jr. is the founder of Rangeley Capital LLC. Rangeley is an investment firm that focuses on event-driven, value-oriented investment opportunities. Rangeley Capital and DeMuth's value investing forum, Sifting the World (StW), search the world for misplaced bets. Rangeley exploits them for its investors and DeMuth writes about them on StW More...

  • Currently 4.60/5

Rating: 4.6/5 (5 votes)

18 Questions With John Huber of Saber Capital Management Goal: 'Make meaningful investments in high-quality businesses at attractive prices' Warren Buffett,Joel Greenblatt,Seth Klarman - 18 Questions With John Huber Of Saber Capital Management
1. How and why did you get started investing? What is your background? More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Eldorado Gold Announces Approval of Revised Normal Course Issuer Bid by the TSX The miner can buy back up to 2,081,168 shares Charles Brandes,Joel Greenblatt - Eldorado Gold Announces Approval Of Revised Normal Course Issuer Bid By The TSX
Eldorado Gold Corp. (NYSE:EGO) (TSX:ELD) announced on Monday that The Toronto Stock Exchange has approved its revised normal course issuer bid (NCIB), which allows the Canadian miner to buy back its own shares “through the facilities of the TSX and also through alternate Canadian trading systems.” More...

GOLD, MINING, ELDORADO


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

AbbVie Files for Approval of Hepatitis C Treatment in the US The application is backed by relevant results and the company will apply in Europe in the first quarter of 2017 David Dreman,Joel Greenblatt - AbbVie Files For Approval Of Hepatitis C Treatment In The US
AbbVie (NYSE:ABBV) announced today through PRNewswire that it has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration for its “investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P).” More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

How to Invest in Gold in 2017 Examining how gold stocks performed in the past year George Soros,Joel Greenblatt - How To Invest In Gold In 2017
With gold trending down, many investors interested in the industry are wondering which step to take. When the time comes, one of the ways to decide which gold mining stocks to invest in is analysing the characteristics of the gold industry and learning from the gurus’ moves. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

CEO of Intrexon Invests in Company Insider purchases 34,606 shares Joel Greenblatt,John Burbank,Murray Stahl - CEO Of Intrexon Invests In Company
Randal Kirk (Insider Trades), CEO and 10% owner of Intrexon Corp. (XON), purchased 34,606 shares on Dec. 13. The price per share was $28.90 for a total transaction of $1,000,113. More...

RANDAL KIRK, INTREXON CORP, INSIDER TRADES


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Watchlist Wednesday: Top 5 Magic Formula Stocks Breakdown of 5 profitable companies trading at low prices Joel Greenblatt - Watchlist Wednesday: Top 5 Magic Formula Stocks
In this edition of Watchlist Wednesday, these are the top five stocks qualifying for the Magic Formula stock screen. More...

VALUE INVESTING, STOCKS, MAGIC FORMULA, JOEL GREENBLATT, QUICK PICKS


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Joel Greenblatt More Than Doubles Home Depot Stake Company is the largest home improvement retailer based on net sales Joel Greenblatt - Joel Greenblatt More Than Doubles Home Depot Stake
Guru Joel Greenblatt (Trades, Portfolio) more than doubled his stake in The Home Depot (NYSE:HD) during the third quarter, adding 345,905 shares of the company at an average price of $133.26 per share. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Transplant Patients Show Improvement With Imbruvica Researchers observed a general response rate of 67% NWQ Managers,Joel Greenblatt,David Dreman,Mario Ga - Transplant Patients Show Improvement With Imbruvica
AbbVie Inc. (NYSE:ABBV) announced Tuesday through PR Newswire that results indicate ibrutinib (trade name Imbruvica), a type of chemotherapy drug for the treatment of patients suffering from “chronic graft-versus-host disease (cGVHD),” is effective and safe. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Pioneer Investments Continues to Buy Alibaba, 8 Others Some of the firm's largest buys of the last 2 quarters Pioneer Investments,Joel Greenblatt,Jim Simons,Ste - Pioneer Investments Continues To Buy Alibaba, 8 Others
Pioneer Investments operates in wide areas of investment vehicles: mutual funds, single manager hedge funds, funds of hedge funds, structured products, segregated and managed accounts, institutional funds. In both the second and third quarters the guru bought shares in the following stocks: More...

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK